Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
GENVEC Add to My Watchlist (NSDQ: GNVC) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     GenVec 1.72 +0.04 (+2.38%) 1,641,271
65 West Watkins Mill Road
Gaithersburg, MD 20878 US
(240) 632-0740
(240) 632-0735 fax
www.genvec.com
CEO Dr. Paul H. Fischer, Ph.D.
Auditor KPMG LLP
Exchange Traded NQ
ISIN Number US37246C1099
CIK Number 934473
NAICS Code 325412
Business Summary
A clinical stage biopharmaceutical company, engaged in the development of novel, gene-based therapeutic drugs and vaccines.
Number of Employees 98
Share Fundamentals
Market Cap 182.90M
Shares Outstanding 106.34M
Float 93.48M
Short Interest 9.58M
Financial Strength
Revenue (TTM) $13,826,000
Earnings (TTM) -$20,466,000
Quick Ratio 3.1:1
Current Ratio 3.2:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs